Browse > Article
http://dx.doi.org/10.5487/TR.2008.24.1.017

Inhibition of Dermatitis Development by Sopungsan in Nc/Nga Mice  

Pokhare, Yuba Raj (College of Pharmacy, Chosun University)
Lim, Sung-Chul (Department of Pathology, College of Medicine, Chosun University)
Kim, Sang-Chan (Department of Prescription, College of Oriental Medicine, Daegu Haany University)
Choi, Hoo-Kyun (College of Pharmacy, Chosun University)
Kang, Keon-Wook (College of Pharmacy, Chosun University)
Publication Information
Toxicological Research / v.24, no.1, 2008 , pp. 17-22 More about this Journal
Abstract
Sopungsan (SS) is a traditional Korean decoction used for the treatment of dermatitis. The aim of this study is to confirm whether or not SS has a preventive effect on the development of atopic dermatitis in dinitrochlorobenzene-applied Nc/Nga mice. SS was administered orally to Nc/Nga mice, which led to the remarkable suppression of the development of dermatitis, as determined by a histological examination and the serum IgE levels. Moreover, SS inhibited the production of thymus- and activation-regulated chemokine (TARC) and its mRNA expression in a keratinocyte cell line, HaCaT, which had been stimulated with tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) and interferon-${\gamma}$ (IFN-${\gamma}$). Activation of the nuclear factor-${\kappa}B$ (NF-${\kappa}B$) or activator protein-1 (AP-1) is one of key steps in the signaling pathways mediating induction of TARC. In this study, SS selectively suppressed NF-${\kappa}B$ activation which may be essential for TARC expression in $TNF-{\alpha}/IFN-{\gamma}$ treated keratinocytes. The inhibitory effect of SS on NF-${\kappa}B$ activation and TARC production might be associated with the anti-dermatitic effects of SS.
Keywords
Atopic dermatitis; Anti-dermatitic activity; $NF-{\kappa}B$; Sopungsan; TARC;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lee, J.Y., Woo, E.R. and Kang, K.W. (2005). Inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by acteoside through blocking of AP-1 activation. J. Ethnopharmacol., 97, 561-566   DOI   ScienceOn
2 Matsuda, H., Watanabe, N., Geba, G.P., Sperl, J., Tsudzuki, M., Hiroi, J., Matsumoto, M., Ushio, H., Saito, S., Askenase, P.W. and Ra, C. (1997). Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol., 9, 461-466   DOI   ScienceOn
3 Nakayama, T., Hieshima, K., Nagakubo, D., Sato, E., Nakayama, M., Kawa, K. and Yoshie, O. (2004). Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J. Virol., 78, 1665-1674   DOI
4 Kotani, M., Matsumoto, M., Fujita, A., Higa, S., Wang, W., Suemura, M., Kishimoto, T. and Tanaka, T. (2000). Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J. Allerg. Clin. Immunol., 106, 159-166   DOI   ScienceOn
5 Hanifin, J. and Rajka, G. (1980). Diagnostic features of atopic dermatitis. Acta. Dermato-Venereologica, 92, 44-47
6 Park, S.J., Lee, S.G., Baek, J.H., Byun, S.H. and Kim, S.C. (2006). Effect of sopung-san on contact hypersensitivity induced by repeat elicitation of DNCB. Kor. J. Orient. Physiol. Pathol., 20, 623-628   과학기술학회마을
7 Furukawa, H., Takahashi, M., Nakamura, K. and Kaneko, F. (2004). Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis. J. Dermat. Sci., 36, 165-172   DOI   ScienceOn
8 Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S. and Yoshie, O. (1997). The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem., 272, 15036-15042   DOI   ScienceOn
9 Vestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K. and Larsen, C.G. (2000). A Th2 Chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol., 115, 640-646   DOI   ScienceOn
10 Soter, N.A. (1989). Morphology of atopic eczema. Allergy, 44, 16-19   DOI   ScienceOn
11 Sandoval-Lopez, G. and Teran, L.M. (2001). TARC: novel mediator of allergic inflammation. Clin. Exp. Allerg., 31, 1809-1812   DOI   ScienceOn
12 Berin, M.C., Eckmann, L., Broide, D.H. and Kagnoff, M.F. (2001). Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am. J. Resp. Cell. Mol. Biol., 24, 382-389   DOI   ScienceOn
13 Kawasaki, S., Takizawa, H., Yoneyama, H., Nakayama, T., Fujisawa, R., Izumizaki, M., Imai, T., Yoshie, O., Homma, I., Yamamoto, K. and Matsushima, K. (2001). Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J. Immunol., 166, 2055-2062   DOI
14 Leung, D.Y. (1997). Atopic dermatitis: immunobiology and treatment with immune modulators. Clin. Exp. Immunol., 107, 25-30
15 Komine, M., Kakinuma, T., Kagami, S., Hanakawa, Y., Hashimoto, K. and Tamaki, K. (2005). Mechanism of thymusand activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol., 125, 491-498   DOI   ScienceOn